Beam Therapeutics Inc. (BEAM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Beam Therapeutics Inc.

    NASDAQ: BEAM · Real-Time Price · USD
    18.48
    -0.28 (-1.49%)
    At close: Sep 04, 2025, 3:34 PM

    Beam Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 63.52M 377.71M 60.92M 51.84M
    Cost of Revenue
    		 n/a 437.38M 22.58M 16.44M
    Gross Profit
    		 63.52M -59.67M 38.34M 35.4M
    Operating Income
    		 -415.57M -176.49M -338.48M -392.46M
    Interest Income
    		 n/a n/a 15.3M 9K
    Pretax Income
    		 -376.7M -131.16M -260.18M -370.64M
    Net Income
    		 -376.74M -132.53M -263.59M -341.36M
    Selling & General & Admin
    		 111.53M 116.81M 87.81M 57.22M
    Research & Development
    		 367.56M 437.38M 311.59M 387.09M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 479.09M 554.19M 399.4M 444.31M
    Interest Expense
    		 n/a n/a 15.3M 9K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 479.09M 554.19M 399.4M 444.31M
    Income Tax Expense
    		 39K 1.37M 3.41M -29.28M
    Shares Outstanding (Basic)
    		 82.31M 77.15M 70.02M 64.23M
    Shares Outstanding (Diluted)
    		 82.31M 77.15M 70.02M 64.23M
    EPS (Basic)
    		 -4.58 -1.72 -3.76 -5.31
    EPS (Diluted)
    		 -4.58 -1.72 -3.76 -5.31
    EBITDA
    		 -383.98M -156.47M -324.33M -392.46M
    EBIT
    		 -415.57M -176.49M -338.48M -370.63M
    Depreciation & Amortization
    		 31.59M 20.01M 22.58M 16.44M

    Add to Watchlist